mRNA |
Roscovitine |
FIMM |
pan-cancer |
AAC |
-0.027 |
0.9 |
mRNA |
Cytarabine |
FIMM |
pan-cancer |
AAC |
-0.025 |
0.9 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0044 |
0.9 |
mRNA |
FQI-2 |
CTRPv2 |
pan-cancer |
AAC |
0.0047 |
0.9 |
mRNA |
selumetinib:vorinostat (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0052 |
0.9 |
mRNA |
STF-62247 |
GDSC1000 |
pan-cancer |
AAC |
-0.005 |
0.9 |
mRNA |
tamatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.0053 |
0.9 |
mRNA |
alisertib |
CTRPv2 |
pan-cancer |
AAC |
0.0044 |
0.9 |
mRNA |
KIN001-266 |
GDSC1000 |
pan-cancer |
AAC |
0.0051 |
0.9 |
mRNA |
myricetin |
CTRPv2 |
pan-cancer |
AAC |
-0.0052 |
0.9 |